Leading the Way in Life Science Technologies

GEN Exclusives

More »
Protagen - Related Content
  • Insight & Intelligence™
  • More »
  • Infographic: Fighting Autoimmune Diseases
    January 2, 2015

    The complex and frequently overlapping symptoms of autoimmune diseases make them exceedingly challenging to diagnose, potentially leading to late or incorrect diagnoses and failed treatments. However, a personalized approach could offer a solution.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »